13F Pro Quality Score

50.5/100

Rank #1,454 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

48.3/100

Profitability

52.2/100

Balance Sheet

59.3/100

Earnings Quality

24.9/100

Free Cash Flow

61.9/100

Institutional Flow

39.0/100

Revenue Scale

49.1/100

Dilution Risk

33.5/100

NOVT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for NOVANTA INC (NOVT), a Technology sector company. 13F Pro's AI-powered ranking engine scores NOVT at 50.5/100 on a 32-signal composite quality model, placing it at rank #1,454 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (24.9) and institutional flow (39.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 33.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), NOVANTA INC reports quarterly revenue of $257.7M, net income of $21.1M, an operating margin of 10.7%. Top institutional holders of NOVT by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, Allspring Global Investments Holdings,, based on the most recent SEC filings. NOVT trades on the Nasdaq exchange and files with the SEC under CIK 1076930. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NOVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NOVANTA INC directly from SEC EDGAR. NOVANTA INC's 13F Pro composite quality score has ranged between 46 and 65 since 2021, currently 50.5 — a stable long-term trajectory across 28 quarterly and live scoring snapshots.

Fun facts about NOVANTA INC

Quirks, history, and lore behind NOVT — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. precision technology company · small-cap · listed on Nasdaq · headquartered in Massachusetts.
  • 2
    The Numbers
    Annual revenue in the range of roughly $900 million, with a focus on high-margin components that go inside other companies' machines rather than consumer products.
  • 3
    The History
    Traces its roots to the early 2000s and has grown largely through acquisitions, stitching together a portfolio of niche precision-technology businesses over two decades.
  • 4
    The Secret
    It makes the laser, motion, and robotics subsystems hidden inside medical and industrial machines — the kind of company whose parts you've never heard of but your surgeon has used.
  • 5
    The Lore
    Its three core segments — Precision Medicine, Robotics & Automation, and Photonics — serve customers building surgical robots, DNA sequencers, and semiconductor equipment.
  • 6
    The Giveaway
    Ticker NOVT, based in Bedford, Massachusetts — this is the quietly essential motion-and-photonics engine inside the machines that are quietly saving your life.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$257.7M

Net Income

Q1 2026

$21.1M

Free Cash Flow

Q1 2026

$47.5M

Operating Margin

Q1 2026

10.7%

ROIC

Q1 2026

1.8%

D/E Ratio

Q1 2026

0.18

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+3.3% YoY
$980.6MFY 2025
FY22 $860.9MFY23 $881.7MFY24 $949.2MFY25 $980.6M

Net Income

-16.0% YoY
$53.8MFY 2025
FY22 $74.1MFY23 $72.9MFY24 $64.1MFY25 $53.8M

Operating Income

-15.0% YoY
$94.0MFY 2025
FY22 $103.1MFY23 $110.5MFY24 $110.6MFY25 $94.0M

EPS (Diluted)

-16.9% YoY
$1.47FY 2025
FY22 $2.06FY23 $2.02FY24 $1.77FY25 $1.47

Total Assets

+30.1% YoY
$1.81BFY 2025
FY22 $1.24BFY23 $1.23BFY24 $1.39BFY25 $1.81B

Total Debt

-39.8% YoY
$250.8MFY 2025
FY22 $435.5MFY23 $354.4MFY24 $416.6MFY25 $250.8M

Op. Cash Flow

-59.6% YoY
$64.1MFY 2025
FY22 $90.8MFY23 $120.1MFY24 $158.5MFY25 $64.1M

AI Insight: NOVT Financial Trends

Debt nearly halved to $241M in Q2 2026 while revenue hit a fresh $258M high, but operating income remains below year-ago levels.

Total debt collapsed from $459M in Q2 2025 to $241M in Q2 2026, a 47% reduction signaling meaningful deleveraging.

Revenue grew modestly from $236M in Q2 2024 to $258M in Q2 2026, with no quarter exceeding $258M.

Operating income fell sharply to $15M in Q2 2025 and has only partially recovered to $28M in Q2 2026, well below $33M in Q3 2024.

Equity surged from $746M in Q4 2024 to $1,314M in Q4 2025, likely reflecting a capital raise or acquisition-related issuance.

Operating cash flow dropped to $8M–$9M in Q3–Q4 2025 before rebounding to $52M in Q2 2026 — sustainability of that recovery is unproven.

Operating margin in Q2 2025 compressed to roughly 6%, down from 14% in Q3 2024 — margin recovery trajectory warrants close monitoring.

The large equity jump in Q4 2025 suggests a dilutive event; impact on per-share metrics and integration execution remains a key risk.

AI Insight: NOVT Ratio Trends

Profitability has not recovered to Q1 2025 peaks — ROIC remains 4pp below its high despite sequential improvement in Q2 2026.

Operating margin collapsed from 13.9% in Q1 2025 to 6.2% in Q2 2025, then partially recovered to 10.7% in Q2 2026.

ROIC peaked at 11.2% in Q1 2025 and stands at 7.1% in Q2 2026 — a 4.1pp deficit versus the peak.

D/E ratio dropped sharply from 0.57 in Q2 2025 to 0.18 in Q2 2026, indicating meaningful debt reduction.

Net profit margin improved to 8.2% in Q2 2026, the highest reading since Q1 2025's 9.1%.

Q2 2025 margin trough (OpMargin 6.2%, NPM 1.9%) signals a potential one-off hit — recurrence would be a material concern.

ROE at 6.4% in Q2 2026 remains well below Q1 2025's 11.0% — sustained recovery is not yet confirmed.

Debt reduction driving D/E to 0.18 could free capital allocation optionality — watch for reinvestment or shareholder return signals.

Get alerted when NOVT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NOVANTA INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of NOVT

Put NOVT on your watchlist

Track score changes the day NOVANTA INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is NOVT a good stock to buy?

13F Pro's AI-powered analysis of NOVANTA INC (NOVT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NOVT are available on the NOVT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NOVT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NOVT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NOVANTA INC's investment landscape.